and who meet all the clinical criteria for a prescription. 'But these drugs should not be seen as a silver bullet for weight ...

Weight loss pills either reduce appetite, boost metabolism or block fat absorption. Most people lose 5% to 10% of their body ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 ...

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

Novo Nordisk, maker of GLP-1 weight loss drugs, has announced it will make one of its drugs, Wegovy, available to patients who use telehealth services. The first three telehealth services to g ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Such vulnerabilities reveal systemic weaknesses, especially when drugs like Wegovy should only be prescribed under close clinical supervision. A significant concern is the prescription of Wegovy ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide). The injectable prescription ... these weight-loss drugs (including ...

Israeli startup ProFuse Technology has launched a new ... need for extensive animal testing. Guy Nevo Michrowski, CEO and cofounder of ProFuse. Photo courtesy of ProFuse Guy Nevo-Michrowski, CEO and ...

At such a critical moment in US history, we need reporters ... about 1,800 unique paid-for weight-loss ads during a search in January that appeared to be promoting prescription-only medications ...